• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列地尔预防对比剂肾病的疗效:系统评价和荟萃分析。

Efficacy of Alprostadil in Preventing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.

机构信息

Department of Cardiology, The 8th Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.

These authors contributed equally to this paper.

出版信息

Angiology. 2021 Oct;72(9):878-888. doi: 10.1177/00033197211004412. Epub 2021 Apr 15.

DOI:10.1177/00033197211004412
PMID:33853365
Abstract

This study aimed to determine the efficacy of alprostadil in preventing contrast-induced nephropathy (CIN). Eligible studies were searched using the keywords through the databases of PubMed, Cochrane, Embase, China Biological Medicine Database, China National Knowledge Infrastructure, and Vanfun. Quality evaluation of the included studies was conducted according to international evidence evaluation and recommended Grades of Recommendations Assessment, Development, and Evaluation standards. We included 29 studies with 5623 patients. Compared with hydration, 10 µg/d alprostadil or 20 µg/d alprostadil plus hydration significantly decreased the incidence of CIN. Compared with hydration, alprostadil plus hydration significantly reduced serum creatinine and blood urea nitrogen at 24, 48, and 72 hours and 7 days after coronary angiography (CAG). Alprostadil (20 µg/d) plus hydration significantly decreased serum cystatin versus hydration at 24, 48, and 72 hours after CAG. Compared with hydration, alprostadil plus hydration significantly increased glomerular filtration rate at 24 and 72 hours after CAG. Alprostadil plus hydration significantly decreased neutrophil gelatinase-associated lipocalin levels compared to hydration at 24, 48, and 72 hours after CAG. Alprostadil plus hydration significantly decreased urine macroglobulin versus hydration at 24 and 48 hours after CAG.

摘要

本研究旨在确定前列地尔预防对比剂诱导肾病(CIN)的疗效。通过使用关键词在 PubMed、Cochrane、Embase、中国生物医学文献数据库、中国国家知识基础设施和万仿数据库中搜索符合条件的研究。根据国际证据评估和推荐的建议评估、制定和评估标准对纳入研究进行质量评估。我们纳入了 29 项研究,共 5623 名患者。与水化相比,10 µg/d 前列地尔或 20 µg/d 前列地尔加水化显著降低 CIN 的发生率。与水化相比,前列地尔加水化在冠状动脉造影(CAG)后 24、48 和 72 小时和 7 天显著降低血清肌酐和血尿素氮。与水化相比,CAG 后 24、48 和 72 小时,前列地尔(20 µg/d)加水化显著降低血清胱抑素。与水化相比,前列地尔加水化在 CAG 后 24 和 72 小时显著增加肾小球滤过率。与水化相比,前列地尔加水化在 CAG 后 24、48 和 72 小时显著降低中性粒细胞明胶酶相关脂质运载蛋白水平。与水化相比,前列地尔加水化在 CAG 后 24 和 48 小时显著降低尿巨球蛋白。

相似文献

1
Efficacy of Alprostadil in Preventing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.前列地尔预防对比剂肾病的疗效:系统评价和荟萃分析。
Angiology. 2021 Oct;72(9):878-888. doi: 10.1177/00033197211004412. Epub 2021 Apr 15.
2
Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.前列地尔对预防造影剂肾病的作用:36项随机对照试验的荟萃分析
Angiology. 2019 Aug;70(7):594-612. doi: 10.1177/0003319719825597. Epub 2019 Jan 22.
3
The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.前列地尔对糖尿病患者经皮冠状动脉介入治疗中预防对比剂肾病的作用:一项系统评价和荟萃分析。
Medicine (Baltimore). 2016 Nov;95(46):e5306. doi: 10.1097/MD.0000000000005306.
4
Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis.前列地尔预防对比剂肾病的疗效:一项荟萃分析。
Sci Rep. 2017 Apr 21;7(1):1045. doi: 10.1038/s41598-017-01160-1.
5
Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.前列地尔预防经皮冠状动脉介入治疗患者造影剂肾病的疗效:一项多中心前瞻性随机对照试验。
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):742-750. doi: 10.1002/ccd.27353. Epub 2017 Oct 10.
6
Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.水化联合或不联合N-乙酰半胱氨酸对接受冠状动脉造影和经皮冠状动脉介入治疗患者造影剂肾病的影响。
Mymensingh Med J. 2011 Apr;20(2):264-9.
7
Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.应用普罗布考联合水化预防冠心病患者对比剂诱导的急性肾损伤:一项随机对照试验的系统评价和荟萃分析。
Medicine (Baltimore). 2023 Mar 17;102(11):e33273. doi: 10.1097/MD.0000000000033273.
8
Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.尼可地尔预防对比剂肾病的效果:一项荟萃分析。
Angiology. 2018 Aug;69(7):568-573. doi: 10.1177/0003319717732237. Epub 2017 Sep 26.
9
Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.ST段抬高型心肌梗死患者在接受直接经皮冠状动脉介入治疗时积极补液以预防造影剂肾病(ATTEMPT):随机对照试验ATTEMPT、撤销1(心脏导管插入术后降低造影剂肾病的首项研究)试验的研究设计与方案
Am Heart J. 2016 Feb;172:88-95. doi: 10.1016/j.ahj.2015.10.007. Epub 2015 Oct 20.
10
Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.经皮冠状动脉介入治疗患者中使用前列腺素E1预防造影剂肾病:24项随机对照试验的荟萃分析
Clin Nephrol. 2018 Nov;90(5):313-324. doi: 10.5414/CN109444.

引用本文的文献

1
Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis.联合药物疗法通过抑制内质网应激诱导的细胞凋亡来预防造影剂诱导的急性肾损伤。
Sci Rep. 2024 Dec 30;14(1):32074. doi: 10.1038/s41598-024-83741-5.
2
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury prevention.应对肾毒性风险:对比剂诱导的急性肾损伤预防全面概述
World J Radiol. 2024 Jun 28;16(6):168-183. doi: 10.4329/wjr.v16.i6.168.